Tom Gualtieri-Reed, MBA is a healthcare consultant with Spragens & Associates LLC and Consultant Lead for the Center to Advance Palliative Care's (CAPC's) Payer Initiative. Mr. Gualtieri-Reed has over 25 years of healthcare experience in business operations, strategic development, and analytics. He works extensively with provider and payer organizations to support strategic and business planning, program development, and team function, with a specific interest in addressing the needs of the aging population and those with serious illness. Mr. Gualtieri-Reed earned his MBA from Duke's Fuqua School of Business and his BA in Economics from the College of the Holy Cross.

Stacie T. Pinderhughes, M.D., serves as the Director of Palliative Medicine at Banner Good Samaritan Medical Center and the Chair for the Division of Palliative Care for Banner Health System.

After fellowship training Dr. Pinderhughes moved to one of Mt Sinai's affiliated hospitals in Harlem NY where she developed a model of hospice and palliative care at the end of life that was unique in the United States. This model provided care to medically underserved aging minority populations who have historically not had access to hospice service at life's end.

Dr. Pinderhughes received the prestigious Woman of the Year Award, from the Park Chester branch of the NAACP for her work in improving access to Hospice and Palliative care for underserved minorities.

Michelle L. Templin is Vice President of Strategic Business Development for Managed Health Care Associates, Inc. (MHA). Since 2013, Michelle has led the strategy and management of the MHA ACO Network, which represents the nation's largest network of post-acute care (PAC) providers, including: long term care (LTC), home infusion and specialty pharmacies, DME and respiratory providers, and skilled nursing, assisted living and rehabilitation facilities. Working with ACOs, Medicare Advantage Plans and other payers, the MHA ACO Network assists in defining local Payer/PAC engagement strategies, provides critical resources for acute and post-acute provider connectivity, and analyzes the value of appropriate PAC utilization across the care continuum.

As a business thought leader on post-acute care, Michelle is a frequent presenter at key conferences regarding ACOs and post-acute. She is a member of the National Association of ACOs (NAACOS), the Post-Acute Center for Research (PACCR), and is an active contributor to the Care Coordination Work Group of The Accountable Care Learning Collaborative sponsored by Leavitt Partners.

Michelle received her undergraduate degree from Temple University with a focus on International Business Administration and Strategic Management and holds an MBA from Pepperdine University.

Emily DuHamel Brower is Vice President of Population Health for Atrius Health, an alliance of three medical groups and a home health care and hospice agency in Massachusetts.

Emily has developed opportunities to support transformational work that measurably improves healthcare for Atrius Health patients, including leading Atrius Health's implementation of the Pioneer ACO model, an initiative of CMS' Center for Medicare and Medicaid Innovation. In her position, Brower leads cross-Atrius Health, cross-discipline teams of over 50 people involved in redesigning care, moving from a payer-based to population-based approach for high risk patients.

Dr. Kate Goodrich joined the Centers for Medicare and Medicaid Services in September of 2011 where she serves as Director of the Center for Clinical Standards and Quality (CCSQ). This Center is responsible for over 20 quality measurement and value-based purchasing programs, implementation of the new Merit-based Incentive Payment System and the Improving Medicare Post-Acute Care Transformation Act, quality improvement programs in all 50 states, clinical standards and survey and certification of all providers across the nation, and all coverage decisions for treatments and services for CMS.

Previously, Dr. Goodrich served as the Director of the Quality Measurement and Value-based Incentives Group in CCSQ where she oversaw the implementation of over 20 quality, value-based purchasing and public reporting programs across multiple settings.

Michael L. Millenson is president of Health Quality Advisors LLC and an adjunct associate professor of medicine at Northwestern University's Feinberg School of Medicine. He is the author of the critically acclaimed 1997 book, Demanding Medical Excellence: Doctors and Accountability in the Information Age, which examined quality of care, patient-centered care and patient safety as part of an information revolution transforming medical practice. A former board member of the Society for Participatory Medicine, Millenson began his career as a journalist and was nominated for a Pulitzer Prize three times. He is currently co-principal investigator on a grant examining innovate practices in patient-centered care by Medicare ACOs.

Lina Walker serves as the vice president of health security in AARP's Public Policy Institute, where she leads a team of senior health policy and health services researchers. She has spent nearly 20 years conducting research and publishing on health care and retirement issues. Lina's recent work includes analyzing Medicare reform proposals and their effect on beneficiaries and Medicare's long-term financial status. In addition, she has worked on issues related to the financing of Social Security and Medicaid, private pension reform, long-term care financing, and health and long-term care insurance.

Aparna Higgins, is Senior Vice President Private Market Innovations at America's Health Insurance Plans (AHIP) and Senior Fellow at The Heller School, Brandeis University. At AHIP, she leads her organization's qualitative and quantitative research on health plan innovations in key areas including performance measurement, payment and delivery system reform, chronic care management, and price transparency. Prior to joining AHIP, she was at Booz Allen Hamilton where she led a number of research studies for The Centers for Medicare and Medicaid Services, Department of Health and Human Services (HHS) Assistant Secretary for Planning and Evaluation (ASPE), and the Department of Veterans Affairs.

Chris Bradbury is currently the Integrated Clinical Solutions and Specialty Pharmacy Leader within Cigna Pharmacy Management. In addition to driving our pharmacy clinical strategies and specialty pharmacy business, he leads our Cigna Pharmacy efforts to integrate our pharmacy capabilities and customer touchpoints to support Cigna's overall strategy to engage customers faster and deeper to improve health and lower total healthcare costs.

Prior to joining Cigna in 2013, Bradbury spent fifteen years at Medco Health Solutions where he led many of the PBM's Clinical and Integrated Data Patient Safety Solutions as well as the Population Health, Chronic Care Management and Care Coordination solutions. In addition, he served as a management consultant for six years focused on business strategy, process reengineering, strategic sourcing and benchmarking in the healthcare and financial services industries.

Bradbury earned his Bachelor of Business Administration in Finance from Georgetown University and earned his Master of Business Administration from MIT's Sloan School of Management.

Jamey Millar is Senior Vice President, Managed Markets and Government Affairs for GSK's US Pharmaceuticals. In this capacity, Jamey leads all US payer functions as well as government relations and public policy. Jamey continues to serve as a member of the Corporate Leadership Team as he did in his prior role as Vice President and Head of the US Oncology business.

Jamey has extensive sales and marketing experience working with providers, hospitals, health systems, and public and private payers across therapeutic areas including respiratory, GSK's largest therapeutic area. He has held a number of leadership positions since joining GSK in 2001 including four years in Managed Markets as Vice President, Strategic Pricing, Contracting, and Payer Marketing. Prior to joining GSK, Jamey spent 11 years with Procter & Gamble, where he held a variety of positions, including Country Manager for the UK, Netherlands, and Ireland.

Robert A. Spurr is US Country Head and Vice President, Patient Access and Health Policy for US General Medicines at Novartis Pharmaceuticals Corporation. Bob is responsible for strategically aligning resources to strengthen the value the company brings to customers. He also leads US Health Policy, State Government Affairs, Patient & Specialty Services, and Established Medicines. Bob holds a BS from Keene State College (NH) and an Executive MBA from Rutgers (NJ).

Larry Kocot is a Principal at KPMG, working within the Healthcare and Life Sciences practice in the Washington, DC, office. Mr. Kocot is also the National Leader of the Center for Healthcare Regulatory Insight. Mr. Kocot provides strategic advice to businesses on health care transformation and counsels a wide range of companies on regulatory matters relating to public health care programs, including Medicare and Medicaid.

Mischa Dick is the co-founder of HEI and HealthSignal Partners. He earned an MS in Aeronautical Engineering from the Technical University of Munich and an MBA from the University of Rochester. HEI focuses on the creation of high quality, low cost operations using high engagement methods coupled with Toyota Production Systems as it's foundation. HealthSignal Partners, a wholly owned subsidiary, provides the services and supplemental technology to remove care plan barriers and address social determinants for populations to prevent disease escalation in a cost effective manner.

Dr. Martin Kohn is Chief Medical Scientist at Sentrian, using predictive analytics for home monitoring in patients with complex chronic disease. It identifies, days in advance, patients that are likely to deteriorate to allow time to intervene to mitigate or prevent the deterioration. He is board-certified in emergency medicine and clinical informatics, an alumnus of MIT and Harvard Medical School and has published on clinical, technical and management subjects. Previously, Dr. Kohn was Chief Medical Scientist at IBM Research developing analytic tools for healthcare, including the use of the Watson in healthcare.

Craig is recognized as being a subject matter expert in the use of Telemedicine for practice efficiency and improved patient outcomes. He is a member of the CTel Industry RoundTable, a speaker and educator for the American Academy of Private Physicians, an Advisory Member of the South East Regional Telehealth Resource Center and an advisor for Telemedicine Magazine. His knowledge is called upon to help direct telehealth policy within his home state of Florida and Federal initiatives including Medicare and interstate licensure.

As President and Chief Strategy Officer, Charlie Lougheed is responsible for the healthcare provider go-to-market strategy and solutions for IBM's Watson Health Explorys division. As cofounder and President of Explorys, Charlie has led key areas area within the company including strategy, product design, platform engineering, client services, and marketing. Charlie co-led three rounds of investor financing for Explorys, as well as the sale to IBM in 2015. Explorys was founded in 2009 as a spin-off from Cleveland Clinic. In less than six years, the company became the leader in healthcare big data and value-based-care analytics, spanning 26 healthcare networks, 317 thousand providers, 360 hospitals, and 50 million patients across the United States. Having amassed the World's largest clinical data set, Explorys also served the life sciences and pharmaceutical industry by providing real-world evidence and insight for product planning, research, and safety.

Dr. Basch is an internist in Washington, DC, and the Senior Director for Health IT Quality and Safety, Research, and National Health IT Policy for MedStar Health. Dr. Basch is the chair of the Medical Informatics Committee for the American College of Physicians and a Visiting Scholar in Health IT Policy at the Center for Health Policy at Brookings. Dr. Basch has been recognized as one of the Top 25 Clinical Informaticists by Modern Healthcare, has received the Physician Informatics Leadership Award by HIMSS, and was named by Beckers CIO Magazine as one the 26 Smartest People in Health IT.

Jeff Bullard, MD, is CEO for the behavioral health assessment and tracking tool, Vault, and is a member of the Board of Governors for Catalyst Health Network, a Dallas-Fort Worth based clinically integrated network. Bullard is the founder and serves as CMO of MaxHealth Medical Associates, a community-based primary care center and is founder and medical director of Acuity Brain Center and MaxFitness Peak Performance and Personal Training. He is the current president of the Academy of Allergy and Asthma in Primary Care and serves as a medical advisory board member for multiple healthcare entities.

Elena Tkachev is a Vice President, ACO Analytics at Universal American and supports 22 ACO with over 4,200 physicians serving 236,000 Medicare beneficiaries. She focuses on transforming information into insight to improve managerial operations and prescribe clinical action that enhances beneficiary health outcomes. Previously, Elena worked at McKinsey Healthcare Analytics Group, where she concentrated on design and development of Innovative Population-Based Delivery and Payment Models. Elena also held leadership positions at Horizon BCBS of New Jersey, Anthem and Milliman. Elena earned an MBA from Fordham University and a BS in actuarial science from Maryville University.

Jonathan R. Sugarman, MD, MPH, is the President and CEO of Qualis Health. The Seattle-based nonprofit is recognized as a national leader in improving population health. Qualis Health's services include healthcare quality consulting, health information technology support and care management services for broad range of public and private sector clients across the United States.

Dr. Sugarman regularly advises government and private sector quality measurement and quality improvement initiatives.

Dr. Sugarman has served as President of The American Health Quality Association, President of the Washington Academy of Family Physicians, Chair of the American Academy of Family Physicians' Commission on Quality and Practice, and executive committee member of the American Medical Association-convened Physician Consortium for Performance Improvement. Dr. Sugarman was the founding Site Director of the Seattle Indian Health Board Family Medicine Residency Program.

Dr. Gillam is the Chair of the Department of Cardiovascular Medicine for Atlantic Health System in NJ and Professor of Medicine at Thomas Jefferson University. She is a graduate of McGill and Queen's Universities in Canada and Columbia University in New York. She has clinical interests in valvular heart disease and imaging and has published and lectured extensively in these fields. She is Associate Editor for Circulation: Cardiovascular Imaging.

Dr. Gillam is Past President of the American Society of Echocardiography, President of the National Board of Echocardiography, and a former member of both the Board of Trustees and Board of Governors of the American College of Cardiology. She has had multiple other leadership roles in these and other organizations. She is a member of the CMS Coverage Advisory Committee and previously served as an advisor to the FDA.

Donald Karcher, MD is Professor and Chair of Pathology and Director of Laboratories at the George Washington University Medical Center in Washington, DC, and is President of the Association of Pathology Chairs (APC), the organization of academic departments of pathology in the US and Canada. He serves in a variety of capacities in the College of American Pathologists (CAP), including as Chair of the Accountable Care Organization (ACO) Network and the Value-Based Care Strategy Steering Group. Dr. Karcher lectures nationally on the impact of value-based care on pathology practice and the role of pathologists in the value-based health care system.

Vernon Pertelle is the President and CEO, StratiHealth and President and Executive Director, Pulmonary Horizons. Pertelle has served as Benefit Administrator, Kaiser Permanente; Senior Consultant, The Permanente Medical Group; Vice President, Clinical Operations for Catholic Health Initiatives and Assistant Vice President, Tri-City Hospital. Pertelle is a respiratory therapist, licensed nurse, certified case manager and attended the U.S. Navy School for Health Sciences, Southern Illinois University, Carbondale, UCLA Anderson School of Management and Harvard University, Extension School for Strategy and Finance.

Scott Adam Berkowitz, MD, MBA is the Senior Medical Director for Accountable Care for Johns Hopkins Medicine (JHM), Associate Professor of Medicine in the Division of Cardiology and Executive Director of the JHM ACO known as Johns Hopkins Medicine Alliance for Patients, LLC (JMAP). Dr. Berkowitz also helped in leading the Johns Hopkins Community Health Partnership (JCHiP) which was launched through a CMMI Health Care Innovation Award. He completed his education at Yale University, his medical training at Johns Hopkins as well as congressional fellowships on both the Senate Finance and HELP Committees. He has published widely on accountable care and health reform.

Dr. Fisher is Director of the Dartmouth Institute for Health Policy and Clinical Practice and the John E Wennberg Distinguished Professor of Health Policy, Medicine and Community and Family Medicine at the Geisel School of Medicine at Dartmouth.

Dr. Fisher led seminal research on the promise and perils of using large databases for health care research, work that demonstrated how such data could be used to answer important epidemiologic and policy questions. This work was the first to reveal the magnitude of waste in U.S. healthcare and helped to provide the rationale for the transition to value-based payment that is now underway.

Finally, he led the team that provided the theoretical rationale for Accountable Care Organizations and worked with colleagues to adapt the concept in ways that helped lead to its inclusion in the Affordable Care Act and adoption by many private payers.

Jason Dinger is the Chief Executive Officer of MissionPoint Health Partners - one of the first dedicated accountable care organizations created in response to the overwhelming need to improve quality outcomes and lower health care costs. Jason has led MissionPoint since its inception, helping shape its mission and vision while remaining committed to helping underserved members of the community, and is responsible for the strategic, operational and cultural stewardship of the organization. MissionPoint currently serves 250,000 members and over 9,100 providers across the country through custom population health strategies for small and large companies, health systems, and payors.

Prior to joining MissionPoint, Jason served as CEO of Dispensary of Hope, the nation's only fully licensed, charitable medication distributor working across the entire spectrum of healthcare. Jason has also directed Saint Thomas Health Ventures - a social venture arm of Saint Thomas Health in Nashville, TN focused on developing non-acute services such as rehabilitation clinics, sleep centers, clinical research organizations, pharmacies, and other health care services. He's also the former CEO of an international consulting firm that worked with clients such as FedEx, Caterpillar Financial, the Corporation for Public Broadcasting and the World Bank.

Jason received his doctorate in International Leadership and Organizational Development from Vanderbilt University, and continues to study and research advances and challenges in localizing health system delivery. He resides in Nashville, TN with his wife and son.

Dennis was the former President and CEO of Catholic Medical Partners (CMP), one of the top performing Shared Saving Accountable Care Organizations (ACO) in the country. At CMP, Dennis and his leadership team managed over $1 billion in healthcare expenditures using a population health/business model. In his current role with Optimity Advisors, Dennis continues to provide strategic guidance and hands-on support to Optimity's healthcare clients as they create new, high-performing delivery models to improve patient outcomes and control costs.

Dennis has held management positions in a variety of healthcare settings including: a neighborhood health center, an academic medical center and a not for profit health maintenance organization. His professional focus has been designing integrated delivery systems and using the principle and practice of public health and clinical integration.

Scott is a Principal & Consulting Actuary with Milliman. He has experience in premium development, forecasting and budgeting, IBNR modeling, and experience analysis for health insurers in the commercial and Medicare markets. Scott has also assisted hospital systems with healthcare cost benchmarking analyses and managed care contract reviews. He has extensive knowledge of the Affordable Care Act and has worked with numerous insurers in modeling the effects of the ACA on their business.

Prior to joining Milliman, Scott worked at a large nationwide insurer where he was involved with Medicare Advantage and Part D bid development, forecasting and budgeting, IBNR modeling, and mergers & acquisitions due diligence.

Arumani Manisundaram is founding Director for the Center for Connected Health at Adventist HealthCare, based in Rockville, Maryland. Manisundaram is leading as the Chief Technologist for Population Health for the Mid-Atlantic ACO and the One Health Quality Alliance - Clinically Integrated Network. Manisundaram's strategic vision has led the development of Adventist HealthCare's HIE. Manisundaram has propelled the adoption of EHR systems by more than 400+ Physicians in Maryland. He was previously a management consultant with Booz Allen Hamilton as Program Manager for the National Cancer Institute's caGRID (cancer grid). He currently serves on Board of the Mid-Atlantic ACO and the Advisory Board Technology for CRISP - Maryland HIE and the HIE Policy Board for the Maryland HealthCare Commission. He also serves on the Advisory Board of the Maryland Bio-Health Innovation.

Andrew is the Vice President of Finance for Steward Health Care Network, the second largest physician network in Massachusetts. Andrew is responsible for the financial performance of Steward's risk contracts, including Steward's performance in the Medicare NextGen program, BPCI Initiative, and commercial risk arrangements. With 10+ years as a financial and operational leader in the Accountable Care industry, Andrew has expertise in managed care contract performance improvement, budget modeling and forecasting, managed care contract negotiation and operations, and business process improvement.

Steward was one of the first provider organizations in Massachusetts to participate in the Blue Cross Blue Shield Alternative Quality Contract (AQC) and one of only thirteen ACOs that generated enough savings to earn a surplus in the first year. Steward now manages over 300K risk lives, both commercial and Medicare.

Michael Chernew, Ph.D. is the Leonard D. Schaeffer Professor of Health Care Policy at Harvard Medical School. Dr. Chernew's research activities focus on several areas, most notably the causes and consequences of growth in health care expenditures, payment reform, and Value Based Insurance Design (VBID). He is a member of the Congressional Budget Office's Panel of Health Advisors and of the Institute of Medicine Committee on National Statistics. He is the former Vice Chair of the Medicare Payment Advisory Commission, an independent agency established to advise the U.S. Congress on issues affecting the Medicare program. In 2010, he was elected to the Institute of Medicine of the National Academy of Sciences. Dr. Chernew earned his undergraduate degree from the University of Pennsylvania and a doctorate in economics from Stanford University.

David Muhlestein, PhD, JD, is Senior Director of Research and Development at Leavitt Partners. He directs the study of accountable care organizations through the Leavitt Partners Center for Accountable Care Intelligence and leads the firm's quantitative evaluation of health care markets. He is an expert in using policy analysis, economic modeling and applied analytics to understand the evolving health care landscape. His insights have been quoted by publications such as The Wall Street Journal, The Seattle Times and Modern Healthcare. Dr. Muhlestein earned his doctorate in health services research, JD, MHA and MS from The Ohio State University and a BA from Brigham Young University.

Dr. Steven Strongwater, MD is President and CEO of Atrius Health. The Atrius Health practices include Dedham Medical Associates, Granite Medical Group, Harvard Vanguard Medical Associates, and VNA Care Network Foundation.

Prior to joining Atrius, Dr. Strongwater served as Geisinger Health System's Chief Transformation Officer providing leadership for transformation through implementing new models of care and developing strategies and tactics to improve quality, patient experience and value, while leveraging analytics and simulation models to improve care.

Currently Dr. Strongwater serves on the American Health System Pharmaceuticals Commission on Goals, Healthcare Productivity Expert Advisory Panel for the Singapore Ministry of Health Committee on Health Professions and recently completed a term as the Chair of the American Hospital Association's Committee on Health Professions.

Larry Kocot is a Principal at KPMG, working within the Healthcare and Life Sciences practice in the Washington, DC, office. Mr. Kocot is also the National Leader of the Center for Healthcare Regulatory Insight. Mr. Kocot provides strategic advice to businesses on health care transformation and counsels a wide range of companies on regulatory matters relating to public health care programs, including Medicare and Medicaid.

Larry Kocot is a Principal at KPMG, working within the Healthcare and Life Sciences practice in the Washington, DC, office. Mr. Kocot is also the National Leader of the Center for Healthcare Regulatory Insight. Mr. Kocot provides strategic advice to businesses on health care transformation and counsels a wide range of companies on regulatory matters relating to public health care programs, including Medicare and Medicaid.